JAKARTA. PT Hetzer Medical Indonesia Tbk (MEDS), a medical equipment manufacturer established in 2010, will make its debut with its initial public offering (IPO) of 312.5 million shares in Indonesia Stock Exchange (IDX).
The shares issued by MEDS will be equal to approximately 20% of its issued and paid-up capital after IPO. Each share reportedly has a face value of IDR 20, which will be publicly offered for a price ranging between IDR 125 and IDR 175 per share.
Assuming that the price exercised in the IPO is IDR 175 per share, MEDS will potentially raise fresh funds of IDR 54.69 billion in IPO. It will be equivalent to 55.4% of its total equity reported in March 31, 2022.
In the published prospectus, MEDS laid out its plan to allocate most funds gained in the IPO to the working capital. Furthermore, the IPO proceeds will also be utilised to cover capital expenditures, including renovating warehouses, purchasing production machines, and developing products.
The public offering will take place from August 2 to 8, 2022. The allotment and the distribution will follow right after on August 9, 2022, while the listing on IDX is scheduled for August 10, 2022. (KR/ZH)